| Dr Reddys Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500124 |
NSE Symbol : DRREDDY |
P/E(TTM) : 23.29 |
|
ISIN Demat : INE089A01031 |
Div & Yield% : 0.60 |
EPS(TTM) : 57.64 |
|
Book Value(₹) : 322.48 |
Market Cap(₹Cr) : 112,015.49 |
Face Value(₹) : 1.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 19,483.80 | 16,962.50 | 14,405.20 | 13,349.10 | 11,850.40 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 19,483.80 | 16,962.50 | 14,405.20 | 13,349.10 | 11,850.40 |
| Other Income | 862.30 | 591.30 | 482.00 | 801.10 | 743.20 |
| Stock Adjustments | 238.80 | -129.50 | 389.60 | 395.60 | 99.90 |
| Total Income | 20,584.90 | 17,424.30 | 15,276.80 | 14,545.80 | 12,693.50 |
| EXPENDITURE : | |||||
| Raw Materials | 5,278.10 | 4,940.70 | 5,435.50 | 4,518.60 | 3,673.70 |
| Power and Fuel Cost | 454.40 | 398.10 | 326.80 | 291.30 | 290.50 |
| Other Manufacturing Expenses | 1,556.00 | 1,257.90 | 1,038.90 | 953.00 | 814.40 |
| Selling and Administration Expenses | 3,064.60 | 2,782.80 | 2,672.90 | 2,274.90 | 2,026.80 |
| Miscellaneous Expenses | 357.40 | 406.10 | 292.00 | 300.00 | 245.10 |
| Employee Benefit Expenses | 3,085.70 | 2,832.60 | 2,434.60 | 2,270.10 | 2,030.20 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 6,788.70 | 4,806.10 | 3,076.10 | 3,937.90 | 3,612.80 |
| Interest | 21.80 | 16.90 | 38.00 | 46.70 | 47.80 |
| Gross Profit | 6,766.90 | 4,789.20 | 3,038.10 | 3,891.20 | 3,565.00 |
| Depreciation | 975.60 | 923.20 | 814.30 | 835.00 | 789.20 |
| Profit Before Tax | 5,791.30 | 3,866.00 | 2,223.80 | 3,056.20 | 2,775.80 |
| Current Tax | 1,361.80 | 864.10 | 392.60 | 540.10 | 483.90 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | 87.50 | 389.10 | 208.00 | 329.70 | -645.80 |
| Reported Net Profit | 4,342.00 | 2,612.80 | 1,623.20 | 2,186.40 | 2,937.70 |
| Extraordinary Items | 57.81 | -15.75 | -5.69 | 337.02 | -11.15 |
| Adjusted Net Profit | 4,284.19 | 2,628.55 | 1,628.89 | 1,849.38 | 2,948.85 |
| Adjustment below Net Profit | 0.10 | - | - | 0.30 | - |
| Profit/Loss Balance carried down | 17,504.80 | 15,403.00 | 14,137.30 | 12,497.90 | 9,951.10 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 641.50 | 511.00 | 357.50 | 547.30 | 390.90 |
| P & L Balance carried down | 21,205.40 | 17,504.80 | 15,403.00 | 14,137.30 | 12,497.90 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 800.00 | 800.00 | 600.00 | 500.00 | 500.00 |
| Dividend Per Share(Rs) | 40.00 | 40.00 | 30.00 | 25.00 | 25.00 |
| Earnings Per Share-Unit Curr | 260.31 | 156.83 | 97.55 | 131.39 | 176.76 |
| Earnings Per Share(Adj)-Unit Curr | 52.06 | 31.37 | 19.51 | 26.28 | 35.35 |
| Book Value | 1,459.23 | 1,236.56 | 1,111.56 | 1,032.48 | 920.13 |
| Book Value(Adj)-Unit Curr | 291.85 | 247.31 | 222.31 | 206.50 | 184.03 |